Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.52 USD | +0.88% | +2.73% | -9.55% |
May. 28 | Bausch + Lomb's New Intraocular Lens Approved by Health Canada | MT |
May. 28 | Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.55% | 5.41B | |
-7.57% | 177B | |
-6.80% | 65.54B | |
-3.52% | 47.09B | |
+7.55% | 43.43B | |
+8.14% | 41.77B | |
+13.61% | 29.55B | |
+15.53% | 24.83B | |
-6.29% | 23.97B | |
-5.99% | 23.54B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Transcript : Bausch + Lomb Corporation, Q1 2024 Earnings Call, May 01, 2024